A pharmacokinetic-pharmacodynamic model for chemoprotective agents against malaria.
Ontology highlight
ABSTRACT: Chemoprophylactics are a vital tool in the fight against malaria. They can be used to protect populations at risk, such as children younger than the age of 5 in areas of seasonal malaria transmission or pregnant women. Currently approved chemoprophylactics all present challenges. There are either concerns about unacceptable adverse effects such as neuropsychiatric sequalae (mefloquine), risks of hemolysis in patients with G6PD deficiency (8-aminoquinolines such as tafenoquine), or cost and daily dosing (atovaquone-proguanil). Therefore, there is a need to develop new chemoprophylactic agents to provide more affordable therapies with better compliance through improving properties such as pharmacokinetics to allow weekly, preferably monthly, dosing. Here we present a pharmacokinetic-pharmaco
SUBMITTER: Cherkaoui-Rbati MH
PROVIDER: S-EPMC9835136 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA